Citation Tools
PDFRegular and young investigator award abstracts
Clinical trials in progress
384 A Phase 1 study to evaluate the safety, PK, and antitumor activity of AK117, an anti-CD47 monoclonal antibody, in subjects with relapsed/refractory advanced or metastatic solid tumors or lymphomas
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 384 A Phase 1 study to evaluate the safety, PK, and antitumor activity of AK117, an anti-CD47 monoclonal antibody, in subjects with relapsed/refractory advanced or metastatic solid tumors or lymphomas